profit from every $100 of sales.
$0$100
Quanterix
$3.38+16.75% today
-31.6% in 1 year
1-year low $2.421-year high $8.06
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Quanterix sold, what it kept, and what it did with the cash.
Sales went from $105 million in 2022 to $139 million in 2025, with -$107 million of profit last year.
SalesProfit
Quanterix vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Quanterix | No profit yet | ||
 Boston Scientific | 22.0× · Fair price | ||
 Koninklijke Philips | 30.0× · Fair price | ||
 Steris | 31.9× · Expensive | ||
 Zimmer Biomet Holdings | 29.1× · Fair price |
AI analysis
An AI analyst reads Quanterix's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 105 | 121 | 135 | 139 | |
| 45 | 73 | 81 | 65 | |
| -75 | -45 | -53 | -110 | |
| -69 | -36 | -44 | -91 | |
| -100 | -28 | -39 | -107 | |
| -2.61 | -0.75 | -1.00 | -2.51 | |
| 42.7% | 60.3% | 59.9% | 46.7% | |
| -71.2% | -36.9% | -38.8% | -79.2% | |
| -94.9% | -23.4% | -28.4% | -77.3% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 434 | 429 | 407 | 419 |
| Cash | 339 | 174 | 57 | 30 |
| Total debt | 44 | 41 | 37 | 37 |
| Total liabilities | 76 | 79 | 76 | 123 |
| 358 | 350 | 330 | 296 | |
| 37 | 38 | 38 | 43 | |
| -14.7% | -9.0% | -11.3% | -26.1% | |
| -27.8% | -8.1% | -11.7% | -36.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -49 | -19 | -35 | -77 | |
| 12 | 4 | 3 | 3 | |
| -60 | -23 | -39 | -80 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 15 | 17 | 20 | 21 |
Valuation
- –
- –
- –
- 0.4×
- 1.2×
- –
- –
- -50.0%
- -67.0%
- 0.0%
Profitability
- 46.7%
- -79.2%
- -77.3%
- -61.9%
- -36.1%
- -17.3%
- -35.2%
- -28.4%
- -37.8%
- 22.9%
Growth
- +9.7%
- –
- −107.2%
- –
- +4.3%
Financial health
- –
- 0.13
- 9.6%
- –
- 3.72
- 2.70
- 0.40
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 14%of 948
Bottom 5%of 871
Bottom 45%of 868
Bottom 1%of 985
What analysts expect
- Average price target
- $4.00
- Range
- $4.00 – $4.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | -0.39 | -0.31 | −25.8% |
| Mar 2, 2026 | -0.38 | -0.27 | −40.7% |
| Nov 10, 2025 | -0.36 | -0.23 | −56.5% |
| Aug 7, 2025 | -0.47 | -0.41 | −14.6% |
| May 12, 2025 | -0.53 | -0.69 | +23.2% |
| Mar 17, 2025 | -0.30 | -0.27 | −11.1% |
| Nov 12, 2024 | -0.22 | -0.24 | +8.3% |
| Aug 8, 2024 | -0.25 | -0.27 | +7.4% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
26No pass
Benjamin Graham
72Pass
Philip Fisher
31No pass
Peter Lynch
44No pass
Joel Greenblatt
0No pass
Charlie Munger
31No pass
Terry Smith
32No pass
Questions about Quanterix
Is Quanterix a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Quanterix AI analysis
What does Quanterix do?
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It is in Medical - Devices.
Does Quanterix pay a dividend?
No. Quanterix does not pay a dividend at the moment.
Is Quanterix stock halal?
No. Quanterix does not pass our halal screen: its cash and confirmed interest-bearing investments are 74% of its market value, at or above the 33% limit. How we check
How has Quanterix stock done over the past year?
Down 31.6% over the past twelve months, to $3.38. It traded between $2.42 and $8.06 and is 58.1% below its high.
Who are Quanterix's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Quanterix's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.